These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 15807987

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Influence of formulation on propofol pharmacokinetics and pharmacodynamics in anesthetized patients.
    Calvo R, Telletxea S, Leal N, Aguilera L, Suarez E, De La Fuente L, Martin-Suarez A, Lukas JC.
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1038-48. PubMed ID: 15315624
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.
    Knibbe CA, Zuideveld KP, DeJongh J, Kuks PF, Aarts LP, Danhof M.
    Clin Pharmacol Ther; 2002 Dec; 72(6):670-84. PubMed ID: 12496748
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
    Vuyk J, Lichtenbelt BJ, Olofsen E, van Kleef JW, Dahan A.
    Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
    [Abstract] [Full Text] [Related]

  • 6. Early phase pharmacokinetics but not pharmacodynamics are influenced by propofol infusion rate.
    Masui K, Kira M, Kazama T, Hagihira S, Mortier EP, Struys MM.
    Anesthesiology; 2009 Oct; 111(4):805-17. PubMed ID: 19741485
    [Abstract] [Full Text] [Related]

  • 7. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
    de la Fuente L, Lukas JC, Vázquez JA, Jauregizar N, Calvo R, Suárez E.
    Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
    [Abstract] [Full Text] [Related]

  • 8. Maturational pharmacokinetics of single intravenous bolus of propofol.
    Allegaert K, de Hoon J, Verbesselt R, Naulaers G, Murat I.
    Paediatr Anaesth; 2007 Nov; 17(11):1028-34. PubMed ID: 17897267
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion.
    Kim KM, Choi BM, Park SW, Lee SH, Christensen LV, Zhou J, Yoo BH, Shin HW, Bae KS, Kern SE, Kang SH, Noh GJ.
    Anesthesiology; 2007 May; 106(5):924-34. PubMed ID: 17457123
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic profile of the induction dose of propofol in chronic renal failure patients undergoing renal transplantation.
    de Gasperi A, Mazza E, Noè L, Corti A, Cristalli A, Prosperi M, Sabbadini D, Savi MC, Vai S.
    Minerva Anestesiol; 1996 May; 62(1-2):25-31. PubMed ID: 8768021
    [Abstract] [Full Text] [Related]

  • 11. Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol.
    Cox EH, Knibbe CA, Koster VS, Langemeijer MW, Tukker EE, Lange R, Kuks PF, Langemeijer HJ, Lie-A-Huen L, Danhof M.
    Pharm Res; 1998 Mar; 15(3):442-8. PubMed ID: 9563075
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of drug action in disease states. VI. Effect of experimental diabetes on phenobarbital concentrations in rats at onset of loss of righting reflex.
    Danhof M, Hisaoka M, Levy G.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):435-8. PubMed ID: 3871481
    [Abstract] [Full Text] [Related]

  • 13. Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients.
    Bienert A, Wiczling P, Zaba C, Zaba Z, Wolc A, Marciniak R, Grześkowiak E, Kusza K.
    Arzneimittelforschung; 2011 Feb; 61(10):545-52. PubMed ID: 22164962
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic changes of methotrexate after intravenous administration to streptozotocin-induced diabetes mellitus rats.
    Park JM, Moon CH, Lee MG.
    Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):343-52. PubMed ID: 8896045
    [Abstract] [Full Text] [Related]

  • 15. Influence of time of day on propofol pharmacokinetics and pharmacodynamics in rabbits.
    Bienert A, Płotek W, Zawidzka I, Ratajczak N, Szczesny D, Wiczling P, Kokot ZJ, Matysiak J, Grześkowiak E.
    Chronobiol Int; 2011 May; 28(4):318-29. PubMed ID: 21539423
    [Abstract] [Full Text] [Related]

  • 16. Predictive ability of propofol effect-site concentrations during fast and slow infusion rates.
    Sepúlveda PO, Cortínez LI, Recart A, Muñoz HR.
    Acta Anaesthesiol Scand; 2010 Apr; 54(4):447-52. PubMed ID: 20003124
    [Abstract] [Full Text] [Related]

  • 17. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
    Kalaiarasi P, Kaviarasan K, Pugalendi KV.
    Eur J Pharmacol; 2009 Jun 10; 612(1-3):93-7. PubMed ID: 19361497
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.